Reference
Li Q-M, et al. Efficacy and safety of different PD-1 inhibitors in combination with lenvatinib in the treatment of unresectable primary liver cancer: a multicentre retrospective study. Discover Oncology 14: Jan 2023. Available from: URL: 10.1007/s12672-023-00708-0
Rights and permissions
About this article
Cite this article
Tislelizumab. Reactions Weekly 2008, 338 (2024). https://doi.org/10.1007/s40278-024-59232-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-59232-5